FHH Fractional Excretion of Calcium Calculator (mg/dL)
Estimate calcium handling using serum and urine calcium and creatinine values. Useful in the diagnostic workup of hypercalcemia, including possible FHH vs primary hyperparathyroidism patterns.
Complete Expert Guide: FHH Fractional Excretion of Calcium Calculator mg/dL
The fhh fractional excretion of calcium calculator mg dl is a practical clinical tool used during evaluation of persistent hypercalcemia. In everyday endocrine and internal medicine practice, clinicians often need to distinguish between two common diagnostic pathways: familial hypocalciuric hypercalcemia (FHH) and primary hyperparathyroidism (PHPT). Both conditions can present with elevated serum calcium, and both may show inappropriately normal or elevated PTH levels. The challenge is that the management implications are very different. FHH is usually benign and often managed conservatively, while PHPT may require surgery in selected patients.
Fractional excretion of calcium is one of the key biochemical clues because it captures how much filtered calcium is excreted in urine relative to creatinine handling. In FHH, calcium excretion is usually low for the level of serum calcium. In many PHPT cases, calcium excretion is higher. This is why calculators that use routine laboratory values in mg/dL are so useful at the bedside or during chart review.
What the calculator actually computes
This calculator uses the commonly applied ratio formula:
Calcium clearance ratio (CCCR) = (Urine Ca x Serum Cr) / (Serum Ca x Urine Cr)
It also displays:
Fractional Excretion of Calcium (FEca %) = CCCR x 100
When values are entered in conventional units (calcium mg/dL and creatinine mg/dL), the ratio is unitless and directly interpretable. If SI units are selected, this page converts values to equivalent conventional units before calculating the same ratio.
Why this matters in possible FHH
FHH is classically linked to variants in genes affecting calcium sensing, most commonly CASR, with less frequent involvement of GNA11 or AP2S1. Because the calcium-sensing setpoint is altered, the kidney reabsorbs more calcium than expected, producing relative hypocalciuria. As a result, the CCCR is often low. A low ratio can prompt genetic evaluation and family screening rather than immediate parathyroid surgery.
By contrast, PHPT is typically due to autonomous parathyroid hormone secretion and may present with kidney stones, reduced bone density, gastrointestinal complaints, neurocognitive symptoms, or asymptomatic biochemical findings. Surgical cure is possible for many PHPT patients, so using urine calcium interpretation correctly is clinically important.
Typical interpretation ranges clinicians use
- CCCR < 0.01: more suggestive of FHH (not diagnostic by itself)
- CCCR 0.01 to 0.02: overlap or indeterminate zone, requires broader clinical context
- CCCR > 0.02: often more consistent with PHPT physiology
These thresholds are practical decision aids, not absolute rules. There is measurable overlap, especially with vitamin D deficiency, renal dysfunction, low calcium intake, certain medications, or incomplete urine collection conditions. For this reason, no calculator should be used as a standalone diagnostic test.
Comparison table: FHH versus PHPT biochemical pattern
| Feature | FHH (typical pattern) | Primary Hyperparathyroidism (typical pattern) |
|---|---|---|
| Serum calcium | Mildly elevated, often lifelong and stable | Elevated, may progress over time |
| PTH level | Normal or mildly elevated | Inappropriately normal or elevated |
| Urine calcium excretion | Low or low-normal | Often normal or high |
| CCCR / FEca | Frequently < 0.01 (FEca < 1%) | More often > 0.02 (FEca > 2%) |
| Family history | Often positive for mild hypercalcemia | Usually not inherited in most sporadic cases |
| Response to parathyroidectomy | Usually no normalization if true FHH | Often curative when criteria are met |
Clinical performance and prevalence context
No single threshold perfectly separates FHH from PHPT. Across published cohorts, using a strict CCCR cutoff near 0.01 can yield moderate sensitivity and specificity rather than perfection. In practical terms, this means some PHPT cases can appear low, and some genetically confirmed FHH cases can sit in the gray zone. This is one reason experts combine biochemical data with family history, medication review, vitamin D status, kidney function, and when needed, molecular testing.
| Population statistic | Reported range in literature and clinical references | How it affects calculator interpretation |
|---|---|---|
| PHPT prevalence in general adult populations | Approximately 0.1% to 0.7%, higher in older adults and postmenopausal women | PHPT is much more common than FHH, so pretest probability matters |
| FHH frequency | Rare disorder, often described in the range of roughly 1:10,000 to 1:100,000 depending on ascertainment method | A very low CCCR should trigger consideration of FHH, but confirmation is usually needed |
| Cutoff utility for CCCR < 0.01 | Moderate discrimination with overlap across cohorts | Strong clue, not standalone diagnosis |
| Indeterminate interval 0.01 to 0.02 | Common overlap zone in routine practice | Interpret with full endocrine workup and repeat testing if needed |
Step by step: using this fhh fractional excretion of calcium calculator mg dl
- Select the unit system. If your lab prints calcium and creatinine in mg/dL, keep conventional mode.
- Enter paired serum and urine values from the same clinical period.
- Click Calculate FEca.
- Review both CCCR and FEca percent output.
- Use the interpretation band as a screening aid, then correlate with PTH, vitamin D, renal function, and family history.
Important pitfalls that can distort FEca or CCCR
- Vitamin D deficiency: can reduce urinary calcium and mimic a low ratio.
- Reduced kidney function: changes creatinine and calcium handling, reducing reliability.
- Thiazide diuretics: may lower urinary calcium excretion.
- Lithium therapy: can affect calcium sensing and PTH physiology.
- Inadequate urine sampling: spot samples can be affected by timing and hydration; 24 hour context may help.
- Recent calcium intake changes: very low intake can drive down urinary calcium.
When to consider genetic confirmation
If the biochemical picture repeatedly suggests FHH, especially with family history of mild hypercalcemia across generations, genetic testing can be highly informative. Confirmation can prevent unnecessary surgery and support family counseling. Many expert pathways consider testing when calcium is persistently high, PTH is non-suppressed, urine calcium is low, and CCCR remains near or below the low threshold after correcting reversible factors.
Reference resources from authoritative institutions
- NIH NCBI Bookshelf: Primary Hyperparathyroidism overview
- MedlinePlus (.gov): Blood calcium testing basics
- NIH NCBI Bookshelf: Approach to hypercalcemia in endocrine practice
How to integrate this number into real decision making
A practical workflow is to treat the calculator result as one layer in a structured differential diagnosis. First, confirm hypercalcemia on repeat testing and adjust interpretation for albumin and ionized calcium when appropriate. Next, classify PTH as suppressed versus non-suppressed. In non-suppressed contexts, apply FEca or CCCR and evaluate confounders. If the value strongly suggests FHH and there is compatible family history, discuss genetics before surgery. If the value is clearly above the usual FHH range and the patient meets surgical criteria for PHPT, endocrine referral for definitive management is reasonable.
This approach helps avoid two common errors: missing a surgically correctable PHPT case, and performing surgery on a patient with FHH who is unlikely to benefit. The best outcomes come from combining quantitative tools with clinical judgment, repeat verification, and context specific specialist input.